Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
1.690
-0.015 (-0.88%)
At close: Oct 23, 2026, 4:00 PM EDT
1.710
+0.020 (1.18%)
After-hours: Oct 23, 2026, 7:56 PM EDT
CDIO Revenue
Cardio Diagnostics Holdings had revenue of $5.36K in the quarter ending June 30, 2026, a decrease of -28.29%. This brings the company's total for the last twelve months to $14.45K, down -25.92% year-over-year. In the year 2025, Cardio Diagnostics Holdings had annual revenue of $14.83K, down -57.51%. That makes Cardio Diagnostics Holdings the 47,127th largest company in the world by revenue and 7,137th in the United States.
Revenue (ttm)
$14.45K
Revenue Growth
-25.92%
P/S Ratio
346.12
Revenue / Employee
$850
Employees
17
Market Cap
5.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.83K | -20.07K | -57.51% |
| Dec 31, 2024 | 34.89K | 17.83K | 104.45% |
| Dec 31, 2023 | 17.07K | 16.12K | 1,696.32% |
| Dec 31, 2022 | 950.00 | 49.00 | 5.44% |
| Dec 31, 2021 | 901.00 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xenetic Biosciences | 3.26M |
| Traws Pharma | 2.73M |
| Evogene | 1.66M |
| Longeveron | 1.19M |
| Can-Fite BioPharma | 405.00K |
| AIM ImmunoTech | 95.00K |
| Pulmatrix | 3.00K |
| Creative Medical Technology Holdings | 3.00K |
CDIO News
- 1 month ago - Cardio Diagnostics release new edition of rural health report - TheFly
- 1 month ago - Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges - Business Wire
- 2 months ago - Cardio Diagnostics announces official launch of in-house laboratory in Iowa - TheFly
- 2 months ago - Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City - Business Wire
- 2 months ago - Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026 - Business Wire
- 4 months ago - Cardio Diagnostics announces AHP to cover Epi+Gen CHD, PrecisionCHD - TheFly
- 4 months ago - Atlas Healthcare Physicians to Cover Cardio Diagnostics' Precision Cardiovascular Medicine Tests Across Its Network - Business Wire
- 5 months ago - Cardio Diagnostics to showcase cardiovascular solutions at four conferences - TheFly